[ADVERT]
Share Name Share Symbol Market Type Share ISIN Share Description
Heiq Plc LSE:HEIQ London Ordinary Share GB00BN2CJ299 ORD GBP0.30
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 91.50 91.00 92.00 91.50 91.50 91.50 47,180 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Chemicals 36.9 5.1 3.1 28.8 115

Heiq Share Discussion Threads

Showing 76 to 99 of 500 messages
Chat Pages: Latest  8  7  6  5  4  3  2  1
DateSubjectAuthorDiscuss
26/1/2021
08:48
Hi Tvh H1 revenue was $30m H1 EBIT was $10.9m Perhaps 'nonsensical' isn't the right word but if they've only done $13.5m EBITDA for the full year, then H2 was around breakeven rather than highly profitable like H1. Equally if revenue for the year was $49m, then they've only done $19m in H2 compared to $30m in H1. Perhaps their business model is very lumpy with big license fees for their technology in H1? Whatever the reason is, I can't explain it or understand what it means for 2021, so difficult to say whether this is cheap or expensive or fairly priced. Do you have a view on why H2 seems to be be sharply down on H1? Perhaps you know the company better than I do. Adam
adamb1978
26/1/2021
08:46
Looks like they have really messed up on this announcement. New to the market, they look as though they don’t know how to do a trading statement, it is a really badly worded announcement which leaves more questions than answers. Let’s hope they realise it and put out a clearer statement. Everyone’s taken fright and sellers have taken the price down. I bet the company is shocked by what has happened.
bigwig
26/1/2021
08:41
@ Adam - what's nonsensical? The figures come from their house broker - a new note issued this morning lifts FY20 revenue to $49m from $43m with adjusted EBITDA unchanged.
tvh123
26/1/2021
08:41
id like a few c 130p for long haul
chateaumusar
26/1/2021
08:37
I only had a small holding but am now out. Too much lack of clarity with that trading statement compared to what 'market expectations' are, and what that implied for H2. H1 seemed very good, but perhaps it was an anomoly? There was me praising their market communication yesterday!!!
adamb1978
26/1/2021
08:20
Well said bad gateway.
netcurtains
26/1/2021
08:20
Hi tvh123 Are you sure about those figures? They look nonsensical to me! H1 revenue was $30.1m and H1 EBIT was $10.9m. The investor presentation on their website also says 'Growth has continued into Q3 2020' Therefore if they've only met expectations of EBITDA of $13.5m for the full-year then H2 and Q4 specifically has been terrible. I'm a holder already, though that TU isn't massively helpful for me. I was also planning to add more... Adam
adamb1978
26/1/2021
08:18
Thats under £10m for EBITDA so maybe the fun is over for a while. Will leave at this level for now.
bad gateway
26/1/2021
08:15
well said tvh123! spot on!
netcurtains
26/1/2021
08:06
Revenue for FY20 was forecast to hit $43m, with adjusted EBITDA of $13.5m FY21 revenue forecasts are set at $45m, with a similar adjusted EBITDA to FY20 so not terribly demanding. Not sure if they're cheap anymore though - time will tell
tvh123
26/1/2021
07:49
1 billion facemasks. Mrk cap £298m Portfolio of 200 novel textile technologies. COATs market cap is: £865m So by comparison (if that is fair) we are pretty cheap. Do we also get the Swiss currency thrown in for free or are the accounts in pounds?
netcurtains
26/1/2021
07:31
So "revenue for FY 2020 exceeded market expectations" and "Operating profit for FY 2020 is anticipated to be in line with market expectations". That sounds fairly promising but not overly helpful as the level of revenue isn't disclosed and I'm not sure what market expectations were for either revenue or operating profit. I will shortly find out if buying in yesterday was good timing or not!
impvesta
26/1/2021
07:17
Here is the link to the trading update. https://www.investegate.co.uk/heiq-plc--heiq-/rns/trading-update/202101260700038338M/
masurenguy
26/1/2021
07:11
Looking good under the radar
nw99
26/1/2021
07:11
HeiQ Plc (LSE:HEIQ), an established global brand in materials and textile innovation which operates in high-growth markets, is pleased to provide a trading update for the financial year ended 31 December 2020 ("FY 2020" or "the Period"). The Company expects to report that revenue for FY 2020 exceeded market expectations. This was due to a robust performance delivered by HeiQ's core portfolio of products, including a particularly strong sales performance from its antimicrobial technology, HeiQ Viroblock, which was launched during the Period. Since then, it has been applied to over 1 billion facemasks and won the Swiss Technology Award in Q4 2020. Operating profit for FY 2020 is anticipated to be in line with market expectations, even after the record levels of investment made by the Company in H2 2020 which will provide a strong platform from which it can achieve its long-term goals. HeiQ's trading for the full year to 31 December 2021 has commenced in line with market expectations and management is confident about the Company's prospects for the year ahead. HeiQ co-founder and CEO Carlo Centonze said: "2020 was a milestone year for HeiQ, characterised by rapid growth and innovation. Not only did we respond quickly to the COVID-19 outbreak by bringing HeiQ Viroblock to market early, we did so while also delivering robust sales growth for many existing products within our 200-strong portfolio of novel textile technologies. These achievements solidified our position as a profitable and fast-growing pioneer in the $24 billion textile chemicals market. "Managing to deliver such a strong performance, whilst also executing on our ambition to list in London through an oversubscribed £60 million fundraise, is testament to the hard work and dedication of our global team. Liquidity in the group remains strong and I am confident that continuing investments will allow us to continue to bring new technologies to market at high pace, whilst also building on the strong sales momentum delivered last year. We will monitor the global markets which continue to be affected by the pandemic but are pleased to have started trading in line with market expectations for the current financial year." This announcement contains inside information.
jammytass
26/1/2021
07:07
Can anyone share what market expectations are? Thanks.
bazzer1000
25/1/2021
22:11
Not sure if anyone else saw it but was a good presentation albeit nothing new if you have seen them present before. Key comment for me was that a 2020 FY trading update was imminent which should be positive
otemple3
25/1/2021
10:32
Yep, am looking forward to tonight's session which although I am sure won't contain anything new will be a great opportunity to bring on board some new investors. Was expecting (purely guesswork) there to be a trading update in Jan as company alluded to being ahead of forecasts in their last presentation. May not be this month now but suspect it isn't far away.
otemple3
25/1/2021
08:28
THeir investor presentations are of an unusually high standard for a company which has just IPO'd IMO
adamb1978
24/1/2021
23:55
Chateaumuser filtered. Thanks DaveMac. HEIQ seems like a promising company so lets hope this thread stays with the long term investment case and does not attract short term punters.
melody9999
24/1/2021
20:50
I have been doing a bit of research and tried to find the report that Viroblock is effective against SARS-Cov-2. Has anybody seen this report from the Doherty Institute in Melbourne? It is referred to in all the literature on Viroblock as M.J. (2020) Report on “Viral Stability and Persistence of SARS-CoV-2 on Treated Material”. Doherty Institute for Infection and Immunity, Australia. I can't find it, I asked Heiq to send it to me but got no reply. A search of the Doherty Institute website (which seems like a prestigious Institute) gave nothing. I searched all the M.J's that work there and came up with nothing. The closest thing I can find was from a J.M rather than MJ - see 2nd paragraph of Q3 in htTps://www.doherty.edu.au/news-events/news/dr-julie-mcauley The bigger question is why hasn't this report been published? It is being used to sell Covid protection to worried consumers. I did in my research find the presentation below which has lots of background on Heiq htTp://brubeckskiclub.pl/wp-content/uploads/2020/09/20200414_HeiQ-Viroblock.pdf
davemac3
24/1/2021
19:57
SuperG, Heiq technology is in all types of mask htTps://www.mustangsupply.co.uk/store/Heiq-Viroblock-FFP2-Respirators-10PK-IN-STOCK-p213284423
davemac3
24/1/2021
16:41
Don’t listen to anything CM says.
stevestacey
23/1/2021
23:01
Thanks Dibbs.....yes I suspect CM is just here to wind folk up. He clearly does plenty of research of his own. This was posted by them today on the Argo Blockchain BB ChateauMusar23 Jan '21 - 21:01 - 15537 of 15559 0 0 0 Added here recent
davidosh
Chat Pages: Latest  8  7  6  5  4  3  2  1
ADVFN Advertorial
Your Recent History
LSE
HEIQ
Heiq
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20211206 21:13:53